L. Arranz

Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease

M. González-Gay, M. Hernández‐Guerra, M. Carrillo-Palau, 2021, Journal of clinical medicine.

Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

J. Gisbert, X. Calvet, M. Piqueras, 2019, Journal of Crohn's & colitis.

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection

P. Nos, D. Ginard, L. Pérez-Méndez, 2021, Gastroenterología y Hepatología.

Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry.

A. Lucendo, L. Bujanda, D. Busquets, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

X. Calvet, M. Piqueras, Miguel A Montoro-Huguet, 2022, Journal of clinical medicine.

Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

J. Gisbert, U. Aguirre, M. Piqueras, 2020, United European gastroenterology journal.

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection

P. Nos, D. Ginard, L. Pérez-Méndez, 2022, Gastroenterología y Hepatología (English Edition).

Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease

M. González-Gay, M. Carrillo-Palau, A. Hernández-Camba, 2022, Clinical and translational gastroenterology.

Application of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survival

J. Crespo, E. Quintero, M. Hernández‐Guerra, 2015, United European gastroenterology journal.

QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease

M. González-Gay, J. Llorca, M. Hernández‐Guerra, 2021, Journal of clinical medicine.

Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk

M. González-Gay, M. Hernández‐Guerra, M. Carrillo-Palau, 2021, Journal of clinical medicine.

Hematological Composite Scores in Patients with Inflammatory Bowel Disease

M. Carrillo-Palau, A. Hernández-Camba, I. Alonso-Abreu, 2023, Journal of clinical medicine.